FDA Import Refusal AEK-0879411-5/11/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment AEK-0879411-5/11/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Apr 7, 2022. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 7, 2022
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY99 ANTI-DIABETIC N.E.C.
- Charges
- 75